Fig. 2
Determination of the IC50 of commercial chemotherapeutics in culture of MCF7 cells. Different concentrations of a doxorubicin (0.1; 0.3; 0.4; 0.5 μM); b cisplatin (2.5; 5.0; 10; 25; 50 μM); c 5-Fluouracyl (0.1; 1.0; 2.5; 5; 10 μM); d tamoxifen (2.5; 5; 7.5; 10 μM) and e irinotecan (10; 20; 40; 60 μM) were tested. Cell viability and affected fraction plots represent the mean ± standard deviation of three independent replicates with five replicates